News | June 11, 2009

Covidien to Highlight Technetium-99m Development at SNM

June 12, 2009 - Covidien will be highlighting at the 2009 SNM Annual Conference in Toronto, June 13-17, its abbreviated new drug application (ANDA) for its kit for the preparation of technetium-99m (Tc-99m) sestamibi injection and radiosotope development.

Covidien's generic product is pharmaceutically equivalent to Cardiolite1, a myocardial perfusion imaging agent used for detecting coronary artery disease. With FDA approval of the ANDA, which was filed by the company's Mallinckrodt subsidiary, Covidien's generic product is now available for customers in the United States.

Covidien's will also focus on its co-marketing agreement with Siemens' PETNET to offer high and low energy radioisotopes to nuclear medicine sites. Through the agreement, Coviden Imaging Solutions and PETNET created a network of nuclear imaging product offerings to expand customer access to a wider range of products, including molecular imaging agents, or radioisotopes, designed to illuminate conditions such as cancer or heart disease when doing SPECT and PET scans.

It will also underscore its agreement with Bacock & Wilcox Technical Services Group Inc. to develop technology for the manufacture of molybdenum-99 (Mo-99), the parent isotope of Tc-99m, the most widely used radioisotope for molecular imaging and nuclear medicine procedures. This collaboration is an initial step toward establishing a large-scale U.S. supply of medical isotopes.

For more information: www.covidien.com

Related Content

ISMRM Issues Guidelines for MRI Gadolinium Contrast Agents
News | Magnetic Resonance Imaging (MRI)| August 15, 2017
The International Society for Magnetic Resonance in Medicine (ISMRM) has provided new guidance in the use of contrast...
New PET-CT Scan Improves Detection in Rare Cardiac Condition
News | PET-CT| July 25, 2017
Using a new imaging technique that can diagnose cardiac sarcoidosis much more accurately than traditional tests,...
Guerbet Announces Plans to Streamline Contrast Media Portfolio, gadolinium MRI contrast
News | Contrast Media| July 18, 2017
Guerbet recently announced that it will phase out sales throughout the world of two products: Hexabrix (meglumine and...
ACR Offers Revised Contrast Media in Imaging Manual
News | Contrast Media| July 17, 2017
The American College of Radiology (ACR) recently revised its authoritative guide for the safe and effective use of...
Sponsored Content | Videos | Business| July 13, 2017
Randall Thompson, M.D., outlines three new CPT codes for FFR-CT, a smart phone-based single-lead ECG system and PET n
Novel PET Tracer Detects Small Blood Clots

PET images (MIP 0-60 min) of three Cynomolgus monkeys. Strong signals are detected at the sites where inserted catheters had roughened surfaces. Almost no other background signal is visible. Only accumulation in the gallbladder becomes visible at the bottom of the image. Credit: Piramal Imaging GmbH, Berlin Germany.

News | PET Imaging| July 07, 2017
Blood clots in veins and arteries can lead to heart attack, stroke and pulmonary embolism, which are major causes of...
Sponsored Content | Videos | Clinical Decision Support| June 29, 2017
Rami Doukky, M.D., system chair, Division of Cardiology, professor of medicine, Cook County Health and Hospitals Syst
Bayer Arterion contrast Injector used to administer medical imaging contrast for CT scans.

Bayer Healthcare's Arterion contrast injector system.

Feature | Contrast Media| June 19, 2017 | Dave Fornell
Here are several updates in medical imaging...
Overlay Init